RP 3467
Alternative Names: RP-3467Latest Information Update: 15 Jan 2024
At a glance
- Originator Repare Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA polymerase theta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer